share_log

NewAmsterdam Pharma(NAMS.US) 10% Shareholder Sells US$4.07 Million in Common Stock

Moomoo News ·  Dec 20, 2024 16:31

$NewAmsterdam Pharma (NAMS.US)$ 10% Shareholder ForGrowth NAP B.V. sold 157.23K shares of common stock on Dec 18, 19, 2024 at an average price of $25.8641 for a total value of $4.07 million.

This transaction involves other related parties: Forbion Capital Fund IV Cooperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Cooperatief U.A. and Forbion Growth Management B.V..

1734730303889548234.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment